Cargando…
Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
α-Synuclein (asyn) is a key pathogenetic factor in a group of neurodegenerative diseases generically known as synucleinopathies, including Parkinson's disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA). Although the initial triggers of pathology and progression are...
Autores principales: | Menon, Sindhu, Armstrong, Sabrina, Hamzeh, Amir, Visanji, Naomi P., Sardi, Sergio Pablo, Tandon, Anurag |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124903/ https://www.ncbi.nlm.nih.gov/pubmed/35614915 http://dx.doi.org/10.3389/fneur.2022.852003 |
Ejemplares similares
-
Viral alpha-synuclein knockdown prevents spreading synucleinopathy
por: Menon, Sindhu, et al.
Publicado: (2021) -
Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
por: Visanji, Naomi P., et al.
Publicado: (2019) -
Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies
por: Rcom-H'cheo-Gauthier, Alexandre N., et al.
Publicado: (2016) -
Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies
por: Okita, Yuho, et al.
Publicado: (2017) -
Cardiac Alpha-Synuclein Is Present in Alpha-Synucleinopathies
por: Javanshiri, Keivan, et al.
Publicado: (2022)